Montelukast causes prolonged, potent leukotriene D4-receptor antagonism in the airways of patients with asthma

Clinical Pharmacology and Therapeutics

Volumn 61, Issue 1, 1997, Pages 83-92

  De Lepeleire, Inge ^b   Reiss, Theodore F ^a   Rochette, Felicien ^b   Botto, Albert ^b   Zhang, Ji ^b   Kundu, Sudeep ^b   Decramer, Marc ^b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOTRIENE D4; LEUKOTRIENE D4 RECEPTOR; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; PLACEBO;

ADULT; AIRWAY CONDUCTANCE; AIRWAY RESISTANCE; ARTICLE; ASTHMA; BRONCHOSPASM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG TOLERABILITY; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION TEST; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ACETATES; ADULT; ASTHMA; BRONCHOCONSTRICTION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; HUMANS; LEUKOTRIENE ANTAGONISTS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; QUINOLINES; RECEPTORS, LEUKOTRIENE; TIME FACTORS; TREATMENT OUTCOME;

EID: 0031015528     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(97)90184-3     Document Type: Article

References (31)

1. Griffin M, Weiss JW, Leitch AG, McFadden ER, Corey EJ, Ansten KF, et al. Effects of leukotriene on the airways in asthma. N Engl J Med 1983;308:436-9.
2. 4 in humans. Am Rev Respir Dis 1985;131:368-72.
3. 4 and to methacholine in patients with asthma and normal controls. New Engl J Med 1986;315:480-4.
4. 4 and histamine in exogenous asthma. Br Med J 1985;290:1468-71.
5. 4 in normal subjects: comparison and interaction with methacholine. Am Rev Respir 1987; 136:979-84.
6. 4 increase the release of mucus from human airways in vitro. Am Rev Respir Dis 1982;126:449-51.
7. 4) in human skin. J Invest Dermatol 1983;80: 115-9.
8. Hui KP, Barnes NC. Lung function improvement in asthma with a cysteinyl leukotriene receptor antagonist. Lancet 1991;337:1062-3.
9. 4 receptor antagonist. N Engl J Med 1990;323:1736-9.
10. 4 receptor antagonist in patients with chronic asthma. J Allergy Clin Immunol 1991;87:309.
11. 4 antagonist, MK-679. Am Rev Respir Dis 1993;147:1442-6.
12. 4 receptor antagonist in subjects with bronchial asthma. Am J Respir Crit Care Med 1994;150:618-23.
13. 4 receptor antagonist. Can J Physiol Pharmacol 1995;73:191-201.
14. 4-receptor antagonist, in healthy volunteers. Br J Clin Pharmacol 1995;40:277-80.
15. Dubois AB, Botelho S, Comroe JH Sr. A new method for measuring airway resistance in man using a body plethysmograph. J Clin Invest 1956;35:372-35.
16. Bel EH, van der Plas KH, Sterk PJ. Inhalation challenge testing: validation of a highly efficient method of aerosol generation. Bull Eur Physiopathol Respir 1986;22(suppl):166.
17. Amin RD, Cheng H, Rogers JD. Determination of montelukast in human plasma by liquid chromatography. J Pharm Biomed Anal 1995;13:155-8.
18. 4-induced bronchoconstriction in subjects with asthma: a concentration-effect study of ICI 204-219. Clin Pharmacol Ther 1993;54:430-6.
19. 4 receptor antagonist ICI 204-219. Am Rev Respir Dis 1990;141: 988-92.
20. Ries AL, Clausen JL. Airway resistance. In: Wilson AF, editor. Pulmonary function testing: indication and interpretation. Orlando: Harcourt Brace, 1985; 109-23.
21. Orehek J, Nicholi MM, De Lepeleire I. Influence of a previous, deep inspiration on the spirometric measurements of provoked bronchoconstriction in asthma. Am Rev Respir Dis 1981;123:269-72.
22. Cubeddu LX, Carr ME, Fuenmayor J. Beta-blockade by oral propanolol and labetalol. Clin Pharmacol Ther 1985;37:277-83.
23. 1-antagonist on airway dynamics and responsiveness to inhaled histamine in mild asthma. J Allergy Clin Immunol 1987;80:51-6.
24. Lam S, Chan H, LeRiche JC, Chang-Yeung M, Salari H. Release of leukotrienes in patients with bronchial asthma. J Allergy Clin Immunol 1988;81:711-7.
25. Pliss LB, Ingenito EP, Ingram RH. Responsiveness, inflammation, and effects of deep breaths on obstruction in mild asthma. J Appl Physiol 1989;66: 2298-304.
26. 4 in bronchoalveolar lavage in bronchial asthma and other respiratory diseases. J Allergy Clin Immunol 1989;84:19-26.
27. Christie PE, Tagari P, Ford-Hutchinson AW, Charlesson S, Chee P, Arm JP, et al. Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am Rev Respir Dis 1991;143:1025-9.
28. Chan-Yeung M, Chan MH, Tse KS, Salari H, Lam S. Histamine and leukotrienes release in bronchoalveolar fluid during plicatic acid-induced bronchoconstriction. J Allergy Clin Immunol 1989;84:762-8.
29. 4 after antigen challenge and in acute asthma and allergic rhinitis. Lancet 1989;1:584-7.
30. 4. Proc Natl Acad Sci USA 1983;80:1712-6.
31. Jorg A, Henderson WR, Murphy RC, Klebanoff SJ. Leukotriene generation by eosinophils. J Exp Med 1982;155:390-402.